TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AstraZeneca to cut 1,600 in U.S., U.K.

AZN $46.18 -$0.28

at close on MONDAY

By The Associated Press
Tuesday, March 19, 2013, 12:01 a.m.
 

Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the United States and United Kingdom, as its new CEO starts a major research and development reorganization.

The cuts come just weeks after the company reported big drops in revenue and net income for 2012 and forecast continuing difficulties as generic competition hurts sales.

The job reductions amount to nearly 3 percent of AstraZeneca's 57,200 workers.

worldwide and are part of moves affecting several major AstraZeneca sites in the UK, US and Sweden.

Even the global headquarters will be shifted, from London to Cambridge, England, as the company moves many of its scientists near top centers for bioscience research. Rivals have been doing the same, to be near those talent pools and to increase collaborations with scientists at universities and small biotech companies.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Google Maps opens business doors to online views for shoppers
  2. United tries to woo fliers with upgraded food options
  3. In 10 years as public company, Google has reshaped IPO landscape, more
  4. Many in Pennsylvania can still get benefit of Affordable Care Act
  5. Family Dollar rejects Dollar General offer
  6. Back-to-school season deals just a click away with new services, apps
  7. 5 apps that make you say ‘wow’
  8. Honda recalls Fits to improve their crash resistance
  9. Stock surge pushes S&P 500 to record
  10. Economic indicator rises 0.9% in July
  11. Airline group forecasts uptick in Labor Day travel
Subscribe today! Click here for our subscription offers.